Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami, Azadeh
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. [electronic resource] - Alzheimer's & dementia : the journal of the Alzheimer's Association Nov 2015 - 1316-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1552-5279
10.1016/j.jalz.2014.11.008 doi
Acetylcholinesterase--cerebrospinal fluid
Aged
Alzheimer Disease--cerebrospinal fluid
Amyloid beta-Peptides--cerebrospinal fluid
Biomarkers--cerebrospinal fluid
Brain--diagnostic imaging
Cell Transplantation
Choline O-Acetyltransferase--cerebrospinal fluid
Cognition--physiology
Female
Genetic Therapy--methods
Glucose--metabolism
Humans
Male
Middle Aged
Nerve Growth Factor--genetics
Radionuclide Imaging
Tissue Scaffolds
Treatment Outcome
tau Proteins--cerebrospinal fluid
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. [electronic resource] - Alzheimer's & dementia : the journal of the Alzheimer's Association Nov 2015 - 1316-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1552-5279
10.1016/j.jalz.2014.11.008 doi
Acetylcholinesterase--cerebrospinal fluid
Aged
Alzheimer Disease--cerebrospinal fluid
Amyloid beta-Peptides--cerebrospinal fluid
Biomarkers--cerebrospinal fluid
Brain--diagnostic imaging
Cell Transplantation
Choline O-Acetyltransferase--cerebrospinal fluid
Cognition--physiology
Female
Genetic Therapy--methods
Glucose--metabolism
Humans
Male
Middle Aged
Nerve Growth Factor--genetics
Radionuclide Imaging
Tissue Scaffolds
Treatment Outcome
tau Proteins--cerebrospinal fluid